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Context: It is presumed that the incidence of adrenal adenomas is symmetric between the left and right
adrenal gland; however, anecdotal observations suggest a potential lateralizing asymmetry.
Objective:To investigate the symmetry in detection of adrenal adenomas and relevance to patient care.
Design: Cross-sectional and longitudinal studies.
Population and Setting:One thousand three hundred seventy-six patients with abdominal computed
tomography or magnetic resonance imaging demonstrating benign-appearing adrenal adenomas.
Main Outcome: Location and size of adrenal adenomas.
Results: Left-sided adenomas were discovered in 65% of patients, right-sided in 21%, and bilateral
adenomas in 14%. Among unilateral adenomas, 75% were left-sided. Left-sided adenomas were more
prevalent than right-sided adenomas in each size category except the largest: ,10 mm, 87%; 10 to
19 mm, 74%; 20 to 29 mm, 72%; $30 mm, 56% (P , 0.0001 for each category, except P = 0.19
when$30 mm). Among those with bilateral adenomas, the left-sided adenoma was significantly larger
than the right one in 61% of patients (P , 0.001). There were no significant differences in the baseline
prevalence or incidence of cardiometabolic diseases between patients with left-sided vs right-sided
adenomas during 5.10 (4.2) years of follow-up.
Conclusions: Adrenal adenomas are substantially more likely to be identified on the left adrenal than
the right. This observation may be due to detection bias attributed to the location of the right adrenal,
which may preclude identification of right-sided adenomas until they are substantially larger. These
findings suggest the potential for an underrecognition of right-sided adenomas that may also impair the
accurate detection of bilateral adrenal diseases.
Copyright © 2018 Endocrine Society
This article has been published under the terms of the Creative Commons Attribution Non-
Commercial, No-Derivatives License (CC BY-NC-ND; https://creativecommons.org/licenses/by-nc-
nd/4.0/).
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The frequent use of abdominal cross-sectional imaging has resulted in a high incidence of
incidentally discovered adrenal tumors [1–3]. Multiple large studies suggest that the
prevalence of incidentally discovered adrenal tumors can range to be as high as 4% to 10%
[4, 5]. Although the vast majority of adrenal tumors represent benign adenomas, even benign
adrenal adenomas may secrete excessive adrenal hormones that may contribute to car-
diometabolic disease [6, 7].
Abbreviations: BMI, body mass index; CT, computed tomography; MRI, magnetic resonance imaging.
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It is generally presumed that the detection of adrenal tumors is symmetric, with half the
abnormalities detected on the left, and half detected on the right adrenal gland; however,
prior studies focused on other objectives included data suggesting a potential lateralizing
asymmetry that favored detection of left-sided adrenal tumors [8–10].
These previous observations suggest that the left adrenal gland may be more prone to
developing adrenal neoplasia, or, alternatively, that left-sided adrenal tumors may be
more readily apparent to radiologists and thus result in a detection bias. The anatomy and
location of the left adrenal gland, with ample periadrenal adipose tissue, allow for easier
visualization compared with the right adrenal gland, which is often compressed between
the liver and right kidney. Therefore, we hypothesized that left-sided adrenal adenomas
may be more frequently detected compared with right-sided adrenal adenomas. We
speculated that this observation could have important clinical implications: a left-sided
preference for detecting adrenal adenomas could result in the underdetection of right-
sided adrenal adenomas and unreliable recognition of bilateral adrenal adenomas.
Because the prognostication and treatment of adrenal disorders (i.e., primary aldoste-
ronism, adrenal Cushing syndrome) may depend on reliable identification of unilateral vs
bilateral disease, any lateralizing bias in recognizing adrenal adenomas could impact the
delivery of quality clinical care to patients. In this study, we report the results of a large
and dedicated systematic investigation focused on the laterality of adrenal adenoma
detection.
1. Methods
A. Study Population
The study population was selected from an institutional research registry of all patients
from the Brigham and Women’s Hospital, the Massachusetts General Hospital, and their
affiliated partner hospitals (Fig. 1) [6]. From this registry, we developed a de-identified
research dataset for the present study of patients who had undergone abdominal computed
tomography (CT) or magnetic resonance imaging (MRI) from 1989 to 2016 and had ac-
cessible reports (n = 234,267). From this population, we selected for patients with either
International Classification of Diseases 9 or 10 diagnosis codes for a benign adrenocortical
tumor or text-search results from radiology reports that documented the presence of a
benign adrenal “tumor,” “nodule,” “mass,” “adenoma,” “thickening,” “lesion,” “nodularity,”
or “hypoattenuation.”We excluded patients with known clinical documentation of adrenal
hormonal diagnoses (such as primary aldosteronism, Cushing syndrome, congenital ad-
renal hyperplasia, or pheochromocytoma) and adrenal malignancy to minimize con-
founding (because one of our objectives was to evaluate the association between laterality
of adrenal adenomas and incident cardiometabolic outcomes) and bias (because these
conditions usually trigger more frequent imaging and increased opportunities to detect
adrenal abnormalities). From 5519 potentially eligible patients, we sequentially conducted
detailed chart reviews and analyses on the first 1700 patients arbitrarily generated from
our registry. Following this manual medical record review, we excluded 324 patients who
were either ,18 years old or who had an adrenal mass with radiographic characteristics
that could be inconsistent with a benign adrenal adenoma (e.g., potential adrenal cysts,
hemorrhage, malignancy, metastatic lesions), or who had insufficient imaging data, for a
final sample size of 1376 patients with benign-appearing adrenocortical adenomas. We
considered an individual as having a benign-appearing adenoma when the interpreting
radiologist described the nodule as having lipid-rich attenuation (,10Hounsfield units) on
unenhanced CT imaging, high-contrast washout on CT imaging (when available), amarked
drop in signal intensity on MRI imaging, and/or descriptors that are suggestive of a benign
entity, such as “benign” or “adenoma” or “myelolipoma” [11, 12]. This study was conducted
with the approval from the Institutional Research and Ethics Review Board of our
Hospital.
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B. Assessment of Baseline and Follow-up Characteristics
We reviewed each patient’s electronic medical record to gather data on the location and size of
the adrenal tumor from the earliest available imaging report. The date of this earliest image
was established to be the baseline time point. Very small adrenal abnormalities or tumors
were sometimes reported as a “thickening” or “nodularity” thatwere too small to bemeasured.
For these instances, a default size of 1 mm was assigned to the adenoma. For the remaining
adenomas, we recorded the exact size and location measured by the radiologist who inter-
preted the CT or MRI.
We determined the most recent comprehensive clinical visit, which was established to
be the final follow-up time point. Examples of comprehensive clinical visits included
annual physical examination, primary care, and general internal medicine visits, medical
Figure 1. Patient selection process. The study population was selected from patients who
underwent abdominal CT or MRI at our institution. We arbitrarily reviewed 1700 patients
with adrenal tumors and excluded 324 patients who were ,18 years old, had an adrenal
abnormality not consistent with benign adrenocortical tumor, or had insufficient information
for a final sample size of 1376.
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subspecialty consultations, and preoperative anesthesia consultations. The average follow-up
period was defined as the average time spanning from the earliest radiology report doc-
umenting an adrenal tumor (baseline) to the most recent comprehensive clinic visit (final
follow-up). We collected pertinent demographic information [age, sex, race, and body mass
index (BMI)], smoking status, creatinine level, medical comorbidities (hypertension, pre-
diabetes, type 2 diabetes, hyperlipidemia, coronary artery disease, peripheral arterial dis-
ease, heart failure, myocardial infarction, ischemic stroke, atrial fibrillation, chronic kidney
disease) at both baseline and final follow-up. We also collected data on medication use for
hypertension (angiotensin converting enzyme inhibitors, angiotensin inhibitors, selective
calcium channel blockers, beta-blockers, thiazides), diabetes (oral hypoglycemic, insulin),
hyperlipidemia (statins, fibrates, niacin), and coronary artery disease (aspirin, nitrates) at
both baseline and final follow-up.
We defined hypertension, chronic kidney disease, coronary artery disease, peripheral
arterial disease, atrial fibrillation, myocardial ischemia, and ischemic stroke as any docu-
mented diagnosis. Prediabetes was defined as a documented diagnosis and/or two or more
documented hemoglobin A1c value of 5.7% to 6.4% among patients not taking any hypo-
glycemic agent other thanmetformin. Type 2 diabetes was defined as a documented diagnosis
and/or two or more documented hemoglobin A1c values $6.5%. Composite diabetes was
defined as having either prediabetes or type 2 diabetes. Hyperlipidemia was defined as a
documented diagnosis and/or a low-density lipoprotein cholesterol level of$150 mg/dL (3.89
mmol/L). Composite cardiovascular disease was defined as a documented diagnosis of hy-
pertension, myocardial infarction, ischemic stroke, or peripheral vascular disease. Incident
cardiovascular outcomes were defined as the development of any cardiovascular comorbid-
ities during the follow-up period.
C. Statistical Analysis
Primary analyseswere conducted to assess the prevalence, sidedness, and size of unilateral vs
bilateral adrenal adenomas. Categorical variables for demographic and clinical character-
istics were presented as counts and percentages whereas continuous variables were pre-
sented with means and standard deviations. Differences in means and frequencies were
analyzed using t tests and x2 tests, respectively. In secondary analyses, we used logistic
regression to assess the risk for incident composite cardiovascular disease by laterality and
sidedness of adrenal adenomas in the subset of patients who did not have baseline composite
cardiovascular disease. Models were adjusted for pertinent confounders, including age, sex,
race/ethnicity, BMI, smoking status, and the presence of baseline diabetes or hyperlipidemia.
A two-tailed P value of,0.05 was considered statistically significant. All statistical analyses
were performed using SAS, version 9.4 (SAS Institute, Cary, NC).
2. Results
A. Baseline Characteristics
Demographic and baseline characteristics of study population categorized by those with
unilateral vs bilateral adrenal adenomas are presented in Table 1. The vast majority of
patients (86.4%, n = 1189) had unilateral adrenal adenomas and were more likely to be
younger, female, and nonsmokers when compared with those with bilateral adenomas. In
addition to being older, patients with bilateral adrenal adenomas were more likely to have
hypertension, peripheral arterial disease, and a composite of cardiovascular diseases when
compared with those with unilateral adenomas (Table 1).
B. The Lateralizing Asymmetry of Unilateral Adrenal Adenomas
Among thosewith unilateral adrenal adenomas (n = 1189), left-sided adenomas (75%; n = 894)
were detected three timesmore often than right-sided adenomas (25%; n = 295) (Table 2). This
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finding was similar throughout the duration of the study period. Patients with left-sided
adrenal adenomasweremore likely to be female (70.1% vs 61%,P, 0.01) and have lower BMI
(29.6 vs 31.0, P , 0.01) when compared with those with right-sided adenomas. There was a
marginally higher prevalence of history of prior stroke (4.4% vs 1.7%, P = 0.033) and pe-
ripheral arterial disease (9.1% vs 5.4%, P = 0.05) among those with left-sided adenomas;
however, there were no other significant differences in demographics or comorbidities
(Table 2).
The excess detection of left-sided adenomaswas evident across the entire range of adenoma
sizes, except when adenomas were $30 mm (Table 3). Left-sided adrenal adenomas repre-
sented 87% of adenomas thatwere,10mm in size, 74% of adenomas that were 10 to 19mm in
size, and 72% of adenomas that were 20 to 29 mm in size. However, once adenomas
were $30 mm, the lateralizing asymmetry was attenuated such that the left-sided detection
preference was no longer statistically significant (Table 3). In parallel with the left-sided
Table 1. Baseline Demographic and Clinical Characteristics of Patients with Unilateral Versus
Bilateral Adrenal Adenomas
Characteristic Unilateral Bilateral P Value
Patients, n (%) 1189 (86.4) 187 (13.6)
Mean age, y 61.11 (13.0) 67.08 (11.6) ,0.0001
Sex, %
Female 67.9 60.4 0.054
Male 32.1 39.6
Race, %
White 71.4 67.4 0.056
Black 7.7 7.0
Hispanic 5.8 3.2
Other 15.3 22.5
Mean BMI, kg/m2a 30.0 (6.84) 28.9 (6.73) 0.061
Creatinine, mg/dLb 1.00 (0.76) 0.97 (0.41) 0.56
Smoking status, %
Nonsmoker 39.5 29.4 ,0.01
Current or Past Smoker 60.5 70.6
Comorbidity at baseline,c %
Hypertension 58.5 69.5 0.004
Prediabetes 6.6 9.1 0.21
Type 2 diabetes 21.1 24.1 0.39
Composite diabetes 27.7 33.2 0.14
Hyperlipidemia 50.6 52.4 0.69
Coronary artery disease 15.5 15.0 0.91
Peripheral arterial disease 8.2 14.4 ,0.01
Myocardial infarction 6.5 10.2 0.087
Stroke 3.7 3.2 1.00
Atrial fibrillation 7.4 7.0 1.00
Chronic kidney disease 8.4 9.1 0.78
Composite cardiovascular diseased 72.3 84.3 ,0.001
Medications at baseline,c %
Hypertension 55.1 64.2 0.021
Diabetes 16.9 21.9 0.099
Hyperlipidemia 40.2 46.0 0.15
Coronary heart disease 33.8 42.8 0.020
Average follow-up time,e y (standard deviation) 5.2 (4.29) 4.4 (3.61) 0.031
aNinety-six patients did not have BMI measured at the time of the baseline imaging.
bSeventy patients did not have creatinine measured at the time of the baseline imaging.
cBaseline defined as date of earliest radiologic imaging demonstrating adrenal adenoma.
dComposite cardiovascular disease defined as diagnosis of hypertension, myocardial infarction, cardiovascular
disease, stroke, or peripheral arterial disease.
eFollow-up time defined as the period of time from earliest radiologic image demonstrating adrenal adenoma to the
most recent comprehensive clinic visit.
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detection asymmetry was a size asymmetry. The mean size of right-sided adenomas was
significantly larger than the mean size of left-sided adenomas [19.2 (11.8) vs 14.8 (10.3) mm,
P , 0.0001], a finding that was evident among small-sized (,10 mm) and larger sized
Table 2. Baseline Demographic and Clinical Characteristics of Patients with Left Versus Right
Unilateral Adrenal Adenomas
Characteristic Left Unilateral Right Unilateral P Value
Patients, n (%) 894 (75.2) 295 (24.8)
Mean age, y 61.5 (12.87) 60.1 (13.2) 0.11
Sex, %
Female 70.1 61.0 0.004
Male 29.9 39.0
Race, %
White 72.2 68.8 0.24
Black 8.1 6.4
Hispanic 5.2 7.5
Other 14.6 17.3
Mean BMI, kg/m2a 29.6 (6.70) 31.0 (7.16) ,0.01
Creatinine, mg/dLb 1.01 (0.83) 0.96 (0.50) 0.37
Smoking status, %
Nonsmoker 39.0 41.0 0.58
Current or past smoker 61.0 59.0
Comorbidity at baseline,c %
Hypertension 58.3 59.0 0.84
Prediabetes 6.3 7.5 0.50
Type 2 diabetes 20.8 22.0 0.68
Composite diabetes 27.1 29.5 0.45
Hyperlipidemia 51.0 49.2 0.59
Coronary artery disease 15.4 15.6 0.93
Peripheral arterial disease 9.1 5.4 0.0498
Myocardial infarction 6.5 6.4 1.00
Stroke 4.4 1.7 0.033
Atrial fibrillation 7.6 6.8 0.70
Chronic kidney disease 8.5 8.1 0.90
Composite cardiovascular diseased 72.3 72.3 1.00
Medications at baseline,c %
Hypertension 55.5 53.9 0.64
Diabetes 15.9 20.0 0.11
Hyperlipidemia 40.7 38.6 0.54
Coronary heart disease 34.2 32.5 0.62
Average follow-up time,e y (standard deviation) 5.1 (4.26) 5.5 (4.38) 0.18
aEighty-three patients did not have BMI measured at the time of the baseline imaging.
bSixty-two patients did not have creatinine measured at the time of the baseline imaging.
cBaseline defined as date of earliest radiologic imaging demonstrating adrenal adenoma.
dComposite cardiovascular disease defined as diagnosis of hypertension, myocardial infarction, cardiovascular
disease, stroke, or peripheral arterial disease.
eFollow-up time defined as the period of time from earliest radiologic image demonstrating adrenal adenoma to the
most recent comprehensive clinic visit.
Table 3. Distribution of Unilateral Adrenal Adenomas by Size Categories
Size Category Percentage Distribution Left Percentage Distribution Right P Value
Any size, % (n) 75 (894) 25 (295) ,0.0001
,10 mm, % (n) 87 (246) 13 (37) ,0.0001
$10 mm, % (n) 72 (648) 28 (258) ,0.0001
10–19 mm, % (n) 74 (405) 26 (139) ,0.0001
20–29 mm, % (n) 72 (178) 28 (68) ,0.0001
$30 mm, % (n) 56 (65) 44 (51) 0.19
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($10 mm) adenomas (Table 4). However, this difference in detection size was predominantly
driven by the smallest adenomas (,10 mm) where right-sided adenomas were clearly larger
than left-sided adenomas; with the detection of larger adenomas, the mean size of left-sided
and right-sided adenomas was similar (Table 4).
Because the amount of periadrenal adipose tissue is an important determinant for the
visualization of the adrenal glands and adenomas, we investigated the frequency of left-sided
vs right-sided unilateral adrenal adenomas detected by quartiles of BMI, where BMI
represented a crude proxy for abdominal adiposity (Table 5). Left-sided adrenal adenomas
were detected more frequently in every quartile of BMI; however, there was a nonsignificant
trend suggesting that the proportion of right-sided adenomas detected was greater with
higher BMI (Table 5).
C. Lateralizing Asymmetries of Bilateral Adrenal Adenomas
Among the 187 patients with bilateral adrenal adenomas, 30% (n = 56) of patients had equally
sized left-sided and right-sided adenomas. Of the remaining 70% (n = 131) of patients with
asymmetrically sized bilateral adenomas, most (61%) had a larger left-sided adenoma,
whereas the minority (39%) had a larger right-sided adenoma (P , 0.001).
D. Incident Clinical Outcomes
Patients with unilateral adrenal adenomas were followed longitudinally with serial imaging for
5.2 (4.3) years whereas patients with bilateral adrenal adenomas were followed for 4.4 (3.6)
years. Among patients with unilateral adenomas, left-sided adenomas were longitudinally
followed for 5.1 (4.3) yearswhereas right-sided adenomaswere followed for 5.5 (4.4) years. There
were no significant differences in any incident composite cardiovascular outcomes between
patients with unilateral vs bilateral adenomas, or unilateral left-sided vs right-sided adenomas.
3. Discussion
It is commonly presumed that the frequency and ability to detect adrenal adenomas is
symmetric between the left and the right adrenal glands. In contrast, our findings suggested a
marked threefold greater detection of left-sided unilateral adrenal adenomas compared with
the right side. We observed that left-sided adrenal adenomas were detected more frequently
even when smaller in size than right-sided adenomas; alternatively, right-sided adenomas
were larger than left-sided adenomas when detected. Furthermore, when bilateral adrenal
adenomas were detected, the left-sided adenoma tended to be larger in size than the right-
sided adenoma. Collectively, these findings suggest a potential bias toward the detection of
left-sided adrenal adenomas, but perhaps more importantly, a concern that right-sided
adrenal adenomas need to be significantly larger than left-sided adenomas before they are
detected. This may have two important implications for patient care: (1) the recognition of
right-sided adrenal adenomas may be delayed until a later stage of progressive growth; and
(2) the underrecognition of right-sided adrenal adenomas may result in a substantial inac-
curacy in identifying true bilateral adrenal abnormalities, which may be most relevant for
Table 4. Mean Size of Unilateral Adrenal Adenomas by Size Categories
Size Category Average Size Left Average Size Right P Value
Any size 14.8 (10.3) 19.2 (11.8) ,0.0001
,10 mm 4.3 (3.5) 5.6 (3.3) 0.023
$10 mm 18.8 (9.1) 21.2 (11.3) ,0.001
10–19mm 13.5 (2.9) 13.6 (3.0) 0.92
20–29 mm 23.4 (2.7) 23.7 (2.8) 0.44
$30 mm 38.7 (11.2) 38.5 (12.1) 0.92
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conditions such as primary aldosteronism and adrenal Cushing syndrome where treatment
decisions rely on reliable lateralization.
To our knowledge, the present study is the first study dedicated to investigating the
asymmetry in detecting adrenal adenomas, and it is the largest study to datewith data on this
topic. Prior studies by Kim et al. [8], Debono et al. [9], and Sangwaiya et al. [10] all included
data that also suggested a potential left-sided asymmetry, but had small study populations
and focused on other research objectives. Note that a survey on adrenal incidentalomas by
Mantero et al. [13] observed more right-sided adrenal tumors than those on the left side;
however, the imagingmodality used was predominantly ultrasound, which is not regarded as
sensitive as CT or MRI, and is more often performed to evaluate the right-sided abdominal
organs. Indeed, whenMantero et al. [13] restricted their analysis to the 247 adrenal adenomas
detected byCT imaging alone, the asymmetrywas no longer apparent. Therefore, our findings
substantially extend and build upon these prior observations. Our study was not designed to
investigate the underlying cause for the asymmetry we observed; however, we suspect that
the preferential identification of left-sided adrenal adenomas may be attributable to ra-
diologic detection bias due to the anatomic differences between the left and right adrenal
glands. The left adrenal gland is surrounded by a layer of hypoattenuating retroperitoneal fat
and is located above the left kidney without compression from surrounding structures, thus
allowing for better visualization on abdominal cross-sectional imaging. In contrast, the right
adrenal gland has less surrounding retroperitoneal fat, abuts the liver, and lies between the
liver and kidney, which may obscure recognition of small abnormalities. Indeed, the right
adrenal gland is often compressed in a manner such that the lateral limbs are in-
distinguishable from one another. The proposition of an imaging detection bias favoring the
left adrenal gland is further supported by the observation that left-sided adrenal adenomas
were detected despite being significantly smaller than those on the right, particularly for
adrenal adenomas in smaller size ranges. As the size of the adenomas increased, the ability to
detect both left-sided and right-sided adenomas appeared to equilibrate. This prompted our
attempt to investigate whether BMI, as a crude proxy of visceral adiposity and periadrenal
adipose tissue, influenced the detection asymmetry. We observed only a mild and non-
significant trend suggesting that patients with higher BMI (or greater adiposity) may have
less asymmetry in the detection of adrenal adenomas; however, BMI is not an accurate
measure of abdominal adiposity, and further studies using quantification of visceral and
periadrenal adipose tissue would be required to better test this hypothesis.
Alternatively, another hypothesis for the lateralizing asymmetry we observed could
involve a fundamental predisposition for left-sided adrenal neoplasia. There have been prior
studies that have suggested asymmetry in the detection ofmalignancies of the breast [14–17];
however, to our knowledge, there is limited evidence to support a predisposition for asym-
metric adrenal neoplasia. One of the earliest studies to note a lateralizing asymmetry of
adrenal adenomaswas an autopsy series published by Russi et al. [18] in 1945 that noted that
among 68 unilateral adrenal adenomas, 34 (50%) were found on the left adrenal, 21 (31%)
were found on the right adrenal, and 13 (19%) were found on bilateral adrenal glands. One
potential explanation for this asymmetry may include potential morphologic differences
between the left and right adrenal glands. In one autopsy study in 2001, Lam et al. [19]
examined the adrenal glands of 333 patients and found a significantly greater dimension and
mean weight of the left adrenal gland compared with the right. Similarly, multiple fetal
adrenal development studies have found an asymmetry in the development of the adrenal
Table 5. Distribution of Unilateral Adrenal Adenomas by Quartiles of BMI
BMI Quartiles Left, % (n) Right, % (n) P Value
1. ,24.88 76.5 (267) 23.5 (82) 0.28
2. 24.88–29.0 78.1 (217) 21.9 (61)
3. 29.0–33.8 74.6 (203) 25.4 (69)
4. .33.8 71.4 (207) 28.6 (83)
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glands such as greater mass, volume, thickness, and surface area of the left adrenal gland
compared with the right adrenal gland during gestation [20–22]. A study by Aliab’ev and
Paderov [23] on the adrenal glands of 161 men of different ages also found an asymmetry
marked by greatermass of the left adrenal and its cortex over the right and that the increasing
adrenal mass with age was predominantly due to the growth of cortex in the left adrenal.
Adult adrenal volumetric studies have reported conflicting results on whether there exists a
significant difference between the left and right mean adrenal volume [24–27]. In an analysis
of 154 patients, Carsin-Vu et al. [24] found that the mean volume of left adrenal gland (4.56
1.6cm3) was significantly greater than the mean volume of the right adrenal gland (3.8 6
1.3cm3). Similarly, in a study of 105 patients, Schneller et al. [25] found a significantly greater
left adrenal mean volume (4.84 6 1.67cm3 vs 3.62 6 1.23 cm3) and left adrenal total width
(18.96 6 3.37 mm vs 15.80 6 3.05 mm). However, studies with smaller sample sizes of 40
patients by Nougaret et al. [26] and 81 patients by Wang et al. [27] failed to demonstrate any
significant difference between the left and right adrenal gland volume. If the left adrenal
gland is indeed larger in dimension and greater in volume, then itmay be possible that greater
tissue mass in the left adrenal may potentially lead to greater opportunities for neoplastic
transformation. It may also be possible that the greater left adrenal volume and size could
lead to better visualization of any abnormalities. In addition to differences in morphology,
other differences such as innervation, vascular supply, and venous drainage may also play a
role in the higher frequency of adenomas observed in the left adrenal gland. To´th et al. [28]
conducted a study using viral transneuronal tracing techniques that demonstrated an
asymmetry with greater supraspinal innervation of the left adrenal gland compared with the
right adrenal gland in rodents. Furthermore, although it is recognized that adrenal venous
drainage is asymmetric, studies have also demonstrated asymmetry in vascular supply with
an additional group of posterior arteries supplying the posterior surface of left adrenal gland
in some individuals [29, 30]. These differences in vascular supply and drainage as well as
innervation may further contribute to differences in size and susceptibility to neoplasia.
The findings of this studyhave several important clinical implications.Our data suggest that
in the current era of frequent adrenal incidental findings: (1) there is a substantial detection
bias toward identifying left-sided adrenal adenomas; (2) the detection of right-sided adrenal
adenomasmay be delayed until they are significantly larger, thus resulting in awindow of time
where recommended biochemical screening and surveillance are not conducted and exposure to
autonomous adrenal hormone secretion may go unrecognized; and (3) the ability to detect
bilateral adrenal diseases may be unreliable, particularly when only a left-sided adrenal ab-
normality is seen in conditions such as primary aldosteronism and adrenal Cushing syndrome.
For example, in a prior study by Young et al. [31], when treatment of primary aldosteronism
relied on CT findings alone, 25% of patients would have had unnecessary or inappropriate
unilateral adrenalectomy due to incorrect identification of the responsible adrenal gland or
failure to detect bilateral disease. Similarly, Kempers et al. [32] conducted a systematic review
of 950 patients that demonstrated that CT/MRI failed to identify bilateral disease in 14.6% of
patients and identified the wrong adrenal gland in 3.9% of patients.
An alternative viewpoint is that this detection bias may result in “overevaluation” of
patients with left-sided adrenal adenomas. In other words, the superior ability to recognize
left-sided adenomas may result in more biochemical evaluations and resultant medical or
surgical interventions for those with left-sided adenomas when compared with right-sided
adenomas. Indeed, the higher incidence of left-sided adrenalectomies has been reportedmany
times before [33–38]. Rieder et al. [33] examined consecutive patients receiving laparoscopic
adrenalectomy between 1998 and 2007 in Southern California Kaiser Permanente Hospital
and reported 109 left-sided adrenalectomies and 54 right-sided adrenalectomies (twice as
many left-sided interventions). Similarly, a study from Nancy University Hospital in France
documented 64 left-sided and 36 right-sided adrenalectomies from November 2001 to
November 2007 in 100 consecutive patients (78% more left-sided interventions) [34].
Our findings must be interpreted within the context of our study design. The main limi-
tations of this study are related to the interpretation of radiographic imaging. Very small
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adrenal abnormalities (,5 mm) sometimes could not be quantified with a reliable size mea-
surement, and we therefore assigned them default size of 1 mm; however, we present our data
in both continuous and categorical formats to demonstrate that our observations related to size
were consistent. Furthermore, measurement technique of adrenal adenomas can vary
depending on how radiologists manually place measurement bars in their imaging software,
and our study relied on radiology interpretations made by many heterogeneous evaluators;
however, our findings reflect “real-world” observations and therefore provide a practical
representation of what may be encountered in medical practice. As with all observational
studies suchas ours, there is a risk of bias in the selection of patients; the patients in the present
study did not undergo systematic prospective imaging, rather they were retrospectively se-
lected based on predefined inclusion criteria from a large registry. Our study focused on
nonfunctional and benign-appearing adrenal adenomas to minimize confounding and bias
attributed tohormonally active adenomas andadrenalmalignancies because they are known to
impart higher risk for cardiometabolic disease and are associated with increased frequency of
imaging; thus, our resultsmay not be generalizable to individuals with functional ormalignant
adrenal tumors. Furthermore, we did not have reliable outcomes assessments of all potential
surgical interventions, growth in adenoma sizes, or development of incident hormone excess,
because our study design and electronic medical record system was not designed to uniformly
capture all future events. Thus, even though we suggest that a potential implication of our
findings could be the unreliable biochemical screening and detection of bilateral adrenal
diseases, our present study was not designed to specifically evaluate this.
In conclusion, our findings suggest a strong preferential detection for left-sided vs right-
sided adrenal adenomas. Left-sided adenomas are detected at significantly smaller sizes than
right-sided adenomas, and patients with bilateral adrenal abnormalities more frequently
present with larger left-sided adrenal adenomas. Taken together, these findings may
implicate a radiologic detection bias that has important clinical implications. First, this
asymmetric detection could lead to underrecognition of right-sided adrenal adenomas that
may delay hormonal screening as well as result in overevaluation and treatment of left-sided
adrenal adenomas. Second, these findings may provide one explanation for why detection of
bilateral disease is unreliable on cross-sectional imaging. Clinicians should be aware of this
lateralizing detection asymmetry when evaluating abdominal imaging and managing pa-
tients with adrenal adenomas.
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